Tuberculosis drug serum levels

Comment

C A Peloquin. Clin Infect Dis. 2001.

. 2001 Aug 15;33(4):584-5.

doi: 10.1086/322706.

No abstract available

Comment on

Therapeutic implications of drug interactions in the treatment of human immunodeficiency virus-related tuberculosis.
Burman WJ, Gallicano K, Peloquin C. Burman WJ, et al. Clin Infect Dis. 1999 Mar;28(3):419-29; quiz 430. doi: 10.1086/515174. Clin Infect Dis. 1999. PMID: 10194057 Review. No abstract available.
Tuberculosis recurrence: multivariate analysis of serum levels of tuberculosis drugs, human immunodeficiency virus status, and other risk factors.
Narita M, Hisada M, Thimmappa B, Stambaugh J, Ibrahim E, Hollender E, Ashkin D. Narita M, et al. Clin Infect Dis. 2001 Feb 1;32(3):515-7. doi: 10.1086/318490. Epub 2001 Jan 25. Clin Infect Dis. 2001. PMID: 11170964